Information for Authors
The Journal of Cardiovascular Pharmacology and Therapeutics publishes original basic human studies, original animal studies, and original bench research with potential clinical application to cardiovascular pharmacology and therapeutics. The focus of the experimental studies is translational research. The journal also publishes review articles on basic research, clinical research, editorials, commentaries, points of view, and controversies. Selected journal supplements will also be published. Future focus will include cardioprotective therapies, stem cell therapy, regenerative cardiology, therapies for preventive cardiology (risk factor management), and antiarrhythmic therapies. Case reports will not be accepted.
Editorial Policies
Manuscripts are accepted for consideration on the condition that they are contributed solely to the Journal of Cardiovascular Pharmacology and Therapeutics. No substantial part of a paper may have been published elsewhere, except for a scientific abstract. All work must be original. Previously published long phrases, sentences, and paragraphs (including the author’s own work) must be properly cited in AMA format—anything else will be considered unacceptable. A direct quote of no more than 4 lines from textual material should be enclosed in double quotation marks; if longer than 4 lines it should be formatted as a block extract. Always verify the quote against the original source, and the citation should include the exact page number(s) of the source. Such directly quoted material should be used sparingly. The receipt of your manuscript by the Journal will be acknowledged and a decision regarding its status made as soon as possible. All manuscripts are subject to editorial review. Manuscripts must be written in acceptable English. Manuscripts submitted in poor English will be returned without review. Some manuscripts that are deemed inappropriate for the journal or very low priority by the editorial staff may be returned without review.
English Language Editing Services
Authors who would like to refine the use of English in their manuscripts might consider utilizing the services of SPi, a non-affiliated company that offers Professional Editing Services to authors of journal articles in the areas of science, technology, medicine or the social sciences. SPi specializes in editing and correcting English-language manuscripts written by authors with a primary language other than English. Visit www.prof-editing.com for more information about SPi’s Professional Editing Services, pricing, and turn-around times, or to obtain a free quote or submit a manuscript for language polishing. Please be aware that SAGE has no affiliation with SPi and makes no endorsement of the company. An author’s use of SPi’s services in no way guarantees that his or her submission will ultimately be accepted. Any arrangement an author enters into will be exclusively between the author and SPi, and any costs incurred are the sole responsibility of the author.
Manuscript Preparation
The Journal of Cardiovascular Pharmacology and Therapeutics prefers to receive all manuscript submissions electronically. To submit a manuscript, please follow the instructions below:
Getting Started
1. Launch your web browser (supported browsers include Internet Explorer 6 or higher, Netscape 7.0, 7.1, or 7.2, Safari 1.2.4, or Firefox 1.0.4) and go to the JCPAT’S Manuscript Central homepage (http://mc.manuscriptcentral.com/jcpat).
2. Log-in or click the ‘‘Create Account’’ option if you are a first-time user of Manuscript Central.
3. If you are creating a new account:
- After clicking on ‘‘Create Account’’ enter your name and e-mail information and click ‘‘Next.’’ Your e-mail information is very important.
- Enter your institution and address information as prompted then click ‘‘Next.’’
- Enter a user ID and password of your choice (we recommend using your e-mail address as your user ID) and then select your area of expertise. Click ‘‘Finish’’ when done.
4. Log-in and select ‘‘Author Center.’’
Submitting Your Manuscript
5. After you have logged in, click the ‘‘Submit a Manuscript’’ link on the Author Center screen.
6. Enter data and answer questions as prompted
7. Click on the ‘‘Next’’ button on each screen to save your work and advance to the next screen.
8. You will be prompted to upload your files:
- Click on the ‘‘Browse’’ button and locate the file on your computer.
- Select the description of the file in the drop down next to the Browse button.
- When you have selected all files you wish to upload, click the ‘‘Upload’’ button.
9. Review your submission (in both PDF and HTML formats) before sending to the editors. Click the ‘‘Submit’’ button when you are done reviewing.
You may stop a submission at any phase and save it to submit later. After submission, you will receive a confirmation via e-mail. You can also log-on to Manuscript Central any time to check the status of your manuscript. The editors will inform you via e-mail once a decision has been made. For questions regarding Manuscript Central or the status of your submission, please contact the managing editor, Erin Nelson, at enelson.sagepub@gmail.com.
Submission Letter
The manuscript is to be accompanied by a cover letter that states (1) all the authors have read and approved the final manuscript, (2) all authors have read and approve of the data being presented in the manuscript, and (3) the full name, address, e-mail address, phone, and fax number of the individual to whom correspondence concerning the manuscript is to be sent. The cover letter should be addressed to
Robert A. Kloner, MD, PhD
Editor-in-Chief
Journal of Cardiovascular Pharmacology and Therapeutics
Heart Institute
Good Samaritan Hospital
1225 Wilshire Boulevard
Los Angeles, CA 90017
Phone: (213)-977–4040
Fax: (213)-977–4107
Title Page
On the title page, please include all of the following information:
1. The names, degrees, and professional affiliation (position, department, institution, place) of all authors.
2. The name of the institution where the work reported was done.
3. Acknowledgment of grant support when appropriate.
4. Complete mailing address, telephone, and fax of corresponding author and e-mail addresses of all authors.
The American Medical Association (AMA) Manual of Style, is the standard source of style. For more information on the AMA Manual of Style, please visit http://www.sagepub.com. Under the right-hand sidebar ‘‘Resources for ...’’ click on ‘‘Journal Editors/Authors’’ and then click on ‘‘Editors Guide.’’ Please view page 27 of the PDF for a brief overview of AMA style points.
Abstract
The abstract should be no longer than 250-300 words in length. The abstract should summarize the main points of the paper and be descriptive, narrative, and informative and should include only information that is in the article. Avoid abbreviations. At the bottom of the abstract, please also submit 3-5 keywords for your article.
Body of the Text
For most original manuscripts, the subheadings Introduction, Methods and Materials, Results, Discussion, and Conclusion or Summary are suggested. The introduction should be no longer than 2-3 paragraphs and should provide background and rationale for the study and specifically state the purpose of the study. The methods section should describe what statistical tests were used. The text of the paper should be no longer than 15-20 double-spaced typed pages in most cases. All tables and figures should be referenced in the main text in the order in which they appear. The discussion should stress what is new in the paper and relate the author’s findings to the existing literature. The discussion should show how the findings add to the existing knowledge base of the subject under study.
Abbreviations
Please avoid excessive and unnecessary abbreviations. Keep them to a minimum. The first time an abbreviation is used it should be defined.
Tables
All tables must be cited in text. Tables are to be numbered with Arabic numerals (Table 1, Table 2) in order of their text citation. Each table should be typed (double-spaced throughout) on a separate sheet of paper and should have a title. Use spaces, not vertical rules, to separate columns. Each table should have a legend in sufficient detail to allow understanding without reference to the text.
Figure and Artwork Submission
Artwork includes charts and graphs, maps, photographs, line art, and tables with 17 or more columns.
Electronic Art
Acceptable file formats include the following: TIFF, JPEG, and PDF. Microsoft application files are acceptable for vector art (line art).
Scanned Images
Line art (black and white) images should be scanned as a bitmap at 900ppi. Photos should be scanned as grayscale or CMYK at 300ppi.
References
References should be cited according to the AMA Manual of Style.In the text, please use a superscripted number that correlates with the reference at the end of the manuscript. When several references are cited simultaneously in the text, you can list the superscripted numbers together, for example, ‘‘Many researchers have debated this subject.’’1,2,5,9 Use ‘‘et al’’ for cites of 3 authors or more in text. However, in the references, list up to 6 authors. If there are more than 6 authors, list the first 3 authors and then ‘‘et al.’’ Type references double-spaced at the end of the manuscript numbered in order of appearance in the manuscript. Unpublished data and personal communications should be given as references. Manuscripts in press may be referenced; however, manuscripts that have been submitted for publication but have not been accepted yet should not be referenced. Avoid quoting abstracts where possible.
Journals
Michaud G, McGowan JL, van der Jagt R, et al. Are therapeutic deci-
sions supported by evidence from health care research? Arch Intern
Med. 1998;158:1665-1668.
Book Chapters
Cole BR. Cystinosis and cystinuria. In: Jacobson HR, Striker GE, Klahr
S, eds. The Principles and Practice of Nephrology. Philadelphia,
PA: BC Decker Inc; 1991:396-403.
Books
Sackett DL, Straus SE, Richardson WS, et al. Evidence-based Medicine:
How to Practice and Teach EBM. 2nd ed. New York, NY: Churchill
Livingstone; 2000.
Conflict of Interest Statement
Authors must disclose all current and foreseeable financial and personal relationships that might inappropriately influence their actions and create a conflict of interest. Complete disclosures of conflicts of interest, or the absence of any conflict of interest, must be provided for all authors on a conflict of interest notification page following the title page of the manuscript. Failure to include this information will delay the review process. Each author’s disclosure will be published. Additionally, a Conflict of Interest and Financial Disclosure Form, completed by all authors, must be submitted along with the manuscript. The form is available from the managing editor at enelson.sagepub@gmail.com
Proofreading
Prior to publication, the publisher will send a copyedited and typeset PDF of the manuscript via e-mail to the corresponding author to review. Any corrections and alterations to the article should be submitted to the publisher prior to the deadline given in the e-mail. Authors are responsible for the accuracy of references and statistical computations.
Copyright
An exclusive license to publish for SAGE is a condition of publication. After your article has been accepted for publication by the editor, an exclusive license to publish form must be completed in SAGE Track. It is the responsibility of the contributor (JCPT author) to obtain written permission for copyrighted material (such as figures and tables that have previously been published) from the original publisher and original corresponding author. Obtaining permission may be an issue for papers that are review articles but should rarely if ever occur if the submission is an original contribution. If fees for reproducing copyrighted material are requested by the owner of the copyright, then the contributor (author) is responsible for the payment for such permission. Signed permission letters should be scanned and emailed to the JCPT managing editor, Erin Nelson at enelson.sagepub@gmail.com. They may also be submitted as supplemental material at the time of submission of the paper. If a previously published figure or table is used, and permission has been granted, it is the responsibility of the author to cite the original reference for the figure or table in the figure legend or table legend.
SAGE Open
If you wish your article to be freely available online immediately upon publication (as some funding bodies now require), you can opt for it to be included in SAGE Open on payment of a publication fee. Manuscript submission and refereeing procedure is unchanged, but on acceptance of your article you will be asked to let SAGE know directly if you are choosing SAGE Open. For further information, please visit http:// www.sagepub.com/sageopen.
Advertising and Reprints
Current advertising rates and specifications may be obtained by contacting the advertising coordinator at (805) 410-7160 or by sending an e-mail to advertising@sagepub.com. Reprints may be ordered by using the special reprint order form that will accompany author proofs. If you need another copy of this order form please e-mail reprint@sagepub.com.
